Host Stan Gloss, founder of BioTeam, talks with Aaron Friedman, HealthAI Principal Product Manager at Amazon Web Services, about the launch of Amazon Omics. This new purpose-built service helps healthcare and life science organizations store, query,
and analyze genomic, transcriptomic, and other omics data to generate insights that improve health and advance scientific discoveries. The platform simplifies and accelerates the process of storing and analyzing data for research and clinical
applications.
On the day of the announcement, Friedman discusses why Amazon Omics will best suit small and large biotech companies and make it easier for various organizations to mine their data. He also outlines its key features, how it combines data with other
modalities, and why it lends itself to top-tier multi-omics and multimodal analysis.
Trends from the Trenches boiler: Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam
co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Links from this episode:
Bio-IT World
BioTeam
Amazon Web Services
AWS Omics
Aaron Friedman is the principal product manager for Amazon Omics. In this role, he is responsible for listening to customers, defining requirements, and ensuring that Amazon Web Services (AWS) helps customers advance scientific discovery and precision medicine. Prior to this role, Friedman spent over five years in AWS healthcare and life sciences solutions (HCLS) architecture leadership roles, spending four years as the HCLS tech lead for the AWS Partner Network and then a year and a half as the HCLS tech lead for startups. In those roles, he also built many of the original architectures and patterns for genomics on AWS. Prior to AWS, Friedman was the first technical employee at Human Longevity, a biotech startup delivering omics-guided healthcare solutions. He received his Ph.D. in Biomedical Sciences at UCSD and graduated summa cum laude with a BS in Biomedical Engineering at Washington University in St. Louis.